GLP-1 medications have revolutionized weight loss treatment, but new research suggests growing numbers of people are misusing the drugs. The study, published in Diabetology International, emphasizes ...
For millions of Americans, GLP-1 medications like semaglutide and tirzepatide have reshaped the conversation around weight ...
FDA warns compounded GLP-1s due to 1,700+ adverse event reports, including dosing errors and unapproved formulations affecting patient safety.
The CA Poison Control System says it's receiving constant calls from people reporting getting sick and even hospitalized after taking GLP-1 drugs, many of them unapproved compounds.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results